Company news
Suzhou Novoprotein Scientific Co., Ltd. Class A (SSE:688137) news
Suzhou Novoprotein Scientific Co., Ltd. Class A news releases on 6ix. Latest, Sep 29, 2026: (688137)"NOVOPROTEIN SCIENTIFIC INC."Announcement on Resolutions…
Press releases & updates
(688137)"NOVOPROTEIN SCIENTIFIC INC."Announcement on Resolutions of the 21st Extraordinary Meeting of the 2nd Board of Directors
September 28, 2026
(688137)"NOVOPROTEIN SCIENTIFIC INC."Announcement on Resignation of an Independent Director, By-election of an Independent Director and Adjustment of Members of Special Committees of the Board of Directors
September 28, 2026
(688137)"NOVOPROTEIN SCIENTIFIC INC."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 28, 2026
"NOVOPROTEIN SCIENTIFIC INC."Notice on Convening the 2nd Extraordinary General Meeting in 2026
September 28, 2026
"NOVOPROTEIN SCIENTIFIC INC."Announcement on Extension of Certain Raised Funds Investment Projects
August 27, 2026
"NOVOPROTEIN SCIENTIFIC INC."Announcement on Severe Abnormal Fluctuations in Stock Trading
August 21, 2026
"NOVOPROTEIN SCIENTIFIC INC."Announcement on Abnormal Fluctuations in Stock Trading and Risk Warning of Expected Loss
August 14, 2026
"NOVOPROTEIN SCIENTIFIC INC."Announcement on Abnormal Fluctuations in Stock Trading
August 10, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
June 23, 2026
Announcement on Reply to the Regulatory Inquiry Letter from SSE on Information Disclosure of the 2025 Annual Report
June 10, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 22, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
May 8, 2026
Announcement on Remuneration Plan for Directors and Senior Management Members in 2026
April 28, 2026
Announcement on Change of Sponsor Representative for Continuous Supervision
April 20, 2026
Announcement on Resolutions of the 18th Extraordinary Meeting of the 2nd Board of Directors
April 14, 2026
Announcement on Progress in Repurchasing Shares
April 2, 2026
Announcement on Adjusting Upper Limit of Shares Repurchase Price
March 24, 2026
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
March 20, 2026
Announcement on Result of Shareholding Reduction by Shareholders
March 3, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Earnings Preannouncement for 2025
January 30, 2026
Announcement on Opening New Special Account for Raised Funds, Change of Sponsor Name, and Re-Signing of Tripartite Supervision Agreement
December 30, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
December 10, 2025
Announcement on Shareholding Reduction Plan for Shareholders with Less than 5% Shares
November 27, 2025
Notice on the 2nd Extraordinary General Meeting in 2025
November 25, 2025
Announcement on Opening New Special Account for Raised Funds and Signing Agreement on Three-party Supervision
November 24, 2025
Announcement on Resolutions of the 12th Meeting of the 2nd Board of Supervisors
November 21, 2025
Announcement on Cancellation of Some Special Accounts for Raised Funds
November 13, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 12, 2025
Announcement on Capital Increase to Wholly-owned Subsidiary Using Proceeds from Partial and Own Funds
October 29, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
October 17, 2025
Announcement on Using Temporarily Idle Raised Funds for Cash Management
October 15, 2025
Announcement on the Extension of the Implementation Period for the Share Repurchase Plan
October 13, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 12, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
August 27, 2025
Announcement on Implementation Result of Shares Repurchase and Share Changes
July 28, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
July 2, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
June 27, 2025
"Corporate Value and Return Enhancement" Action Plan 2025
June 25, 2025
Announcement on Opening Special Settlement Account for Cash Management Products Using Raised Funds
June 18, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 29, 2025
Announcement on Results of Share Reduction by Shareholders
May 27, 2025
Notice on Convening the 2024 Annual General Meeting
May 8, 2025
Announcement on Changing the Implementation Sites of Some Investment Projects Financed by Raised Funds and Postponing Investment Projects Financed by Raised Funds
April 28, 2025
Announcement on Changing Project Partners and Signing Accountants
February 27, 2025
Announcement on Share Reduction Plan for Shareholders
February 24, 2025
Announcement on the Results of Shareholding Reduction by Shareholders
January 24, 2025
Announcement on Expected Loss in Annual Performance for 2024
January 17, 2025
Announcement on Convening the Q3 2024 Performance Briefing
November 19, 2024
Announcement on Making Provisions for Asset Impairment in Q1-Q3 2024
October 29, 2024